new and emerging therapies for asthma and copd edward omron md, mph, fccp
DESCRIPTION
Community presentation for new asthma and copd therapies Edward Omron MD, MPH, FCCP Pulmonary Medicine Morgan Hill, CA 95037 www.docomron.comTRANSCRIPT
![Page 1: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/1.jpg)
New and Emerging Therapies for Asthma and COPD
Edward Omron MD, MPH, FCCPPulmonary and Critical Care MedicineSaint Louise Regional Medical Center
![Page 2: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/2.jpg)
What is Asthma?
• Reversible lung disease• The airways of the lung are inflamed, swollen and
narrowed resulting in “wheezing”• Breathing problems occur in “attacks” but the
disease is continuous • Recurrent cough, chest tightness / pain, or shortness
of breath• Symptoms worsen with exercise, infection, changes
in weather, or at night.
![Page 3: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/3.jpg)
Asthma Airways
![Page 4: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/4.jpg)
Asthma Facts
• In 2009, 25 million Americans had asthma– Of these 13 million have had an asthma attack
• In 2007 there were 3500 deaths from asthma– 63% of these deaths occurred in women
• The prevalence of adult asthma in CA 2009 is 8%• Asthma accounts for 50 billion health care dollars
yearly
![Page 5: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/5.jpg)
Types of Asthma
![Page 6: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/6.jpg)
Mainstays of Therapy
Inhaled Corticosteroids Remain the MAINSTAY of treatment in all asthmatic groups
![Page 7: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/7.jpg)
Advances in Therapy
• There is no cure of asthma thus far in 2012• CONFIRM the diagnosis before any
augmentation of treatment of regimens– Rule out for example vocal cord dysfunction– Interstitial Lung Disease
• Severe persistent asthma is a great challenge to both the patient and the physician
![Page 8: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/8.jpg)
Xolair (Omalizumab)• Severe persistent asthmatics with allergies and an
elevated IgE antibody level• IgE is an allergy antibody– It binds to allergens and causes the release of
inflammatory mediators which makes asthma worse
• Xolair binds to IgE antibody and turns it off• Reduced medication use, symptoms, and improved
quality of life • Cost about $1500.00 monthly• Monthly subcutaneous injections
![Page 9: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/9.jpg)
Xolair and IgE
![Page 10: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/10.jpg)
Bronchial Thermoplasty (BT)
• Severe asthmatics have excessive smooth muscle in the airways
• BT is a non-drug procedure that reduces airway smooth muscle by applying heat to the airways– This reduces the frequency of asthma attacks
• Three outpatient procedures performed three weeks apart under sedation
• Benefits:– 32% reduction in asthma attacks– 84% reduction in ER visits– Improved asthma quality of life
![Page 11: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/11.jpg)
Airway Lumen in Severe Asthma
![Page 12: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/12.jpg)
Bronchial Thermoplasty
![Page 13: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/13.jpg)
What is COPD?
• Two irreversible lung diseases that frequently coexist together:– Chronic bronchitis: airways of the lung are inflamed,
swollen and narrowed resulting in “wheezing”• HEAVY mucus or phlegm is coughed up• Breeding ground for recurrent infections
– Emphysema: the scaffolding of the lung is destroyed resulting in multiple “holes”
• Progressive Shortness of Breath associated with chest pressure and exercise limitation
![Page 14: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/14.jpg)
COPD Forms
Bronchitic Emphysematous
![Page 15: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/15.jpg)
COPD Pathology
![Page 16: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/16.jpg)
COPD (Chronic Obstructive Lung Disease)
![Page 17: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/17.jpg)
COPD Facts
• Third leading cause of death in America– 125,000 lives in 2007
• Smoking is the primary risk factor for COPD• Female smokers are 13 times more likely to die from
COPD than females who never smoked• 13 million adults were estimated to have COPD in
2008• 50 Billion in health care costs yearly
![Page 18: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/18.jpg)
COPD CHEST XRAY
![Page 19: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/19.jpg)
COPD/Emphysema CT CHEST
![Page 20: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/20.jpg)
Diagnosis of COPD
• Pulmonary Physician• Appropriate Symptoms• Diagnostic Studies– Chest X-Ray and CT CHEST– Pulmonary Function Study– 6 minute walk test– Arterial Blood Gas– Alpha 1 antitrypsin deficiency
![Page 21: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/21.jpg)
COPD Mimics
• Congestive Heart Failure• Asthma• Bronchiectasis• Interstitial Lung Disease
![Page 22: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/22.jpg)
Pharmacology
• Bronchodilators– B Agonists– Anticholinergics– Xanthines
• Steroids (intravenous inpatient and inhaled outpatient)• Vaccines(influenza and pneumococcus)• Antibiotics• Oxygen• Mucolytics and Flutter/Acapella Valves• Pulmonary rehabilitation
![Page 23: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/23.jpg)
Pulmonary Rehabilitation
![Page 24: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/24.jpg)
What effect does COPD have on my ability to be active?
• Shortness of breath = inactivity• Muscle Weakness = Fatigue• Loss of independence = depression• Isolation• Weight Gain• Immune system weakens
![Page 25: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/25.jpg)
Why should I exercise for COPD?
• Builds Strength• Less shortness of breath• More independence• Greater reserve to fight infection• Less fatigue• Weight control• Quality of life
![Page 26: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/26.jpg)
How do I exercise for COPD?
• Under care of a health professional• Physical Therapist guides training• Stretches• Aerobic Conditioning• How to cough, breath, and train safely
![Page 27: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/27.jpg)
Diaphragmatic Breathing
![Page 28: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/28.jpg)
Elbow Breathing
![Page 29: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/29.jpg)
Pursed Lip Breathing
![Page 30: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/30.jpg)
Pursed Lip Breathing
![Page 31: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/31.jpg)
Advances in Therapy• Indacaterol (Arcapta Neohaler)– Once daily long acting (24 hours) bronchodilator in COPD– Rapid onset with intense bronchodilation– Improvement in shortness of breath, exercise
performance, and quality of life.– Hopefully available later this year, excellent safety profile
![Page 32: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/32.jpg)
Roflumilast (Daliresp)
• Phosphodiesterase inhibitors (similar to caffeine)• Decreases airway inflammation• Not a bronchodilator• Side effects: Headache, Nausea, Diarrhea• Reduces COPD exacerbations• Once daily oral dosing, cannot be used in liver
dysfunction
![Page 33: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/33.jpg)
Alpha-1 Antitrypsin Deficiency
• A genetic condition associated with early onset COPD and liver disease
• Alpha 1-Antitrypsin is a enzyme that protects the lung from enzymes that break down lung tissue
• About 1-3% of patients with COPD are predicted to have alpha1-antitrypsin deficiency.
• Intravenous (IV) augmentation therapy with alpha1-antitrypsin benefits some patients
• Identified in all populations• All COPD patients are now screened for this disorder
![Page 34: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/34.jpg)
Stem Cells in COPD
• Stem cells are derived from the bone marrow– Can regenerate normal lung tissue with manipulation– Several studies in animal models show great promise in
COPD– Too early to comment
• Vitamin D– Early enthusiasm – Most recent study in severe COPD disappointing– No consensus
![Page 35: New and emerging therapies for asthma and copd Edward Omron MD, MPH, FCCP](https://reader033.vdocuments.site/reader033/viewer/2022061218/54b7f9e04a79593d748b45f3/html5/thumbnails/35.jpg)
Resources
• American Lung Association– http://www.lung.org/lung-disease/
• http://www.onebreath.org/• http://www.thoracic.org/education/breathing
-in-america/index.php